Silvant Capital Management’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

Silvant Capital Management’s Portfolio GWPH Stock Details GWPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-2,095	Closed	-$242K	–	347
2020 Q4	$242K	Hold	2,095	–	–	0.04%	177
2020 Q3	$204K	Hold	2,095	–	–	0.04%	175
2020 Q2	$257K	Hold	2,095	–	–	0.05%	154
2020 Q1	$183K	Hold	2,095	–	–	0.04%	158
2019 Q4	$219K	Hold	2,095	–	–	0.04%	175
2019 Q3	$241K	Buy	2,095 +484	+30%	+$73.5K	0.05%	166
2019 Q2	$278K	Buy	+1,611	New	+$279K	0.05%	164

Other funds holding GWPH

PCM

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

GCL

Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return

EMG

ETF Managers Group Summit, New Jersey $3.1B AUM 17.12% 1-Year Est. Return

AAM

Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return

UOC

UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Silvant Capital Management's GWPH Position: Q1 2021 in Review

Silvant Capital Management sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q1 2021, closing a stake of 2,095 shares — an estimated $242K sold.

Silvant Capital Management first reported a position in GWPH in Q2 2019 and held it in 7 quarters. The position peaked at $278K in Q2 2019. 297 funds tracked by Wall St. Rank hold GWPH as of Q1 2021.

Silvant Capital Management reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q1 2021 after selling out during the quarter.
Silvant Capital Management sold 2,095 GW Pharmaceuticals Plc American Depositary Shares shares in Q1 2021, an estimated $242K.
Silvant Capital Management first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q2 2019 and held it in 7 quarters.
Silvant Capital Management's GW Pharmaceuticals Plc American Depositary Shares position peaked at $278K in Q2 2019.
297 funds tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q1 2021.

Based on Silvant Capital Management's 13F filing for Q1 2021, filed 11 May 2021.